Literature DB >> 19542604

The microtubule-associated protein tau is also phosphorylated on tyrosine.

Thibaud Lebouvier1, Timothy M E Scales, Ritchie Williamson, Wendy Noble, Charles Duyckaerts, Diane P Hanger, C Hugh Reynolds, Brian H Anderton, Pascal Derkinderen.   

Abstract

Tau protein is the principal component of the neurofibrillary tangles found in Alzheimer's disease (AD), where it is hyperphosphorylated on serine and threonine residues. It is hypothesized that this hyperphosphorylation contributes to neurodegeneration through the destabilization of microtubules. There is now evidence that phosphorylation of tau can also occur on tyrosine residues. Human tau has five tyrosines numbered 18, 29, 197, 310, and 394, according to the sequence of the longest CNS isoform. Tyrosines 18, 197, and 394 have been shown to be phosphorylated in the brain of patients with AD whereas tyrosine 394 is the only residue that has been described to date that is phosphorylated in physiological conditions. Src family kinases and spleen tyrosine kinase (Syk) have been shown to phosphorylate tyrosine 18 while c-Abl is capable of phosphorylating tyrosine 394. Recently, a dual specificity kinase termed TTBK1 has been characterized in human brain and shown to be able to phosphorylate residue 197 of tau. Data about the role of tau tyrosine phosphorylation in neuronal physiology are still scarce and preliminary. In contrast, there is mounting evidence suggesting that tau tyrosine phosphorylation is an early event in the pathophysiology of AD and that Fyn and c-Abl are critical in the neurodegenerative process which occurs in tauopathies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19542604     DOI: 10.3233/JAD-2009-1116

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  26 in total

1.  Tyrosine nitration within the proline-rich region of Tau in Alzheimer's disease.

Authors:  Juan F Reyes; Yifan Fu; Laurel Vana; Nicholas M Kanaan; Lester I Binder
Journal:  Am J Pathol       Date:  2011-05       Impact factor: 4.307

2.  Complex regulation of p73 isoforms after alteration of amyloid precursor polypeptide (APP) function and DNA damage in neurons.

Authors:  Samir Benosman; Xiangjun Meng; Yannick Von Grabowiecki; Lavinia Palamiuc; Lucian Hritcu; Isabelle Gross; Georg Mellitzer; Yoichi Taya; Jean-Philippe Loeffler; Christian Gaiddon
Journal:  J Biol Chem       Date:  2011-10-14       Impact factor: 5.157

Review 3.  Tau splicing and the intricacies of dementia.

Authors:  Athena Andreadis
Journal:  J Cell Physiol       Date:  2012-03       Impact factor: 6.384

4.  The crystal structure of the catalytic domain of tau tubulin kinase 2 in complex with a small-molecule inhibitor.

Authors:  Douglas J Marcotte; Kerri A Spilker; Dingyi Wen; Thomas Hesson; Thomas A Patterson; P Rajesh Kumar; Jayanth V Chodaparambil
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2020-03-02       Impact factor: 1.056

5.  Saitohin, which is nested within the tau gene, interacts with tau and Abl and its human-specific allele influences Abl phosphorylation.

Authors:  Yan Wang; Lei Gao; Christopher G Conrad; Athena Andreadis
Journal:  J Cell Biochem       Date:  2011-11       Impact factor: 4.429

6.  A genome-wide association study of brain lesion distribution in multiple sclerosis.

Authors:  Pierre-Antoine Gourraud; Michael Sdika; Pouya Khankhanian; Roland G Henry; Azadeh Beheshtian; Paul M Matthews; Stephen L Hauser; Jorge R Oksenberg; Daniel Pelletier; Sergio E Baranzini
Journal:  Brain       Date:  2013-02-13       Impact factor: 13.501

7.  Phosphorylation in the amino terminus of tau prevents inhibition of anterograde axonal transport.

Authors:  Nicholas M Kanaan; Gerardo Morfini; Gustavo Pigino; Nichole E LaPointe; Athena Andreadis; Yuyu Song; Ellen Leitman; Lester I Binder; Scott T Brady
Journal:  Neurobiol Aging       Date:  2011-07-27       Impact factor: 4.673

Review 8.  Roles of tau protein in health and disease.

Authors:  Tong Guo; Wendy Noble; Diane P Hanger
Journal:  Acta Neuropathol       Date:  2017-04-06       Impact factor: 17.088

9.  Tau phosphorylation pathway genes and cerebrospinal fluid tau levels in Alzheimer's disease.

Authors:  Lynn M Bekris; Steve Millard; Franziska Lutz; Gail Li; Doug R Galasko; Martin R Farlow; Joseph F Quinn; Jeffrey A Kaye; James B Leverenz; Debby W Tsuang; Chang-En Yu; Elaine R Peskind
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2012-08-27       Impact factor: 3.568

10.  Tau 6D and 6P isoforms inhibit polymerization of full-length tau in vitro.

Authors:  Nichole E Lapointe; Peleg M Horowitz; Angela L Guillozet-Bongaarts; Andres Silva; Athena Andreadis; Lester I Binder
Journal:  Biochemistry       Date:  2009-12-29       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.